Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Lacosamide Vimpat Anticonvulsant 2010/10/21
Lapatinib ditosylate Tykerb Antineoplastic agent 2009/05
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Ledipasvir + sofosbuvir Harvoni Antiviral agent 2015/01/07
Lemborexant Dayvigo Hypnotic 2020/11/06
Lenalidomide Revlimid Antineoplastic agent
Letermovir Prevymis Antiviral agent 2017/12/20
Letrozole Femara Non-steroidal aromatase inhibitor; inhibitor of estrogen biosynthesis; antitumor agent
Levodopa, carbidopa, entacapone Stalevo Anti-parkinson drugs 2010/08/03
Levomilnacipran Fetzima Antidepressant 2016/10/16
Levonorgestrel Jaydess Intrauterine System Progestogen 2013/11/01
Levonorgestrel Backup Plan Onestep Contraceptive agent 2016/01/28
Lifitegrast Xiidra Lymphocyte function associated antigen-1 (LFA-1) antagonist 2017/12/22
Linaclotide Constella Guanylate cyclase-C agonist 2014/05
Linagliptin Trajenta Oral antihyperglycemic agent 2011/09/13
Linagliptin + metformin Jentadueto Oral antihyperglycemic agent 2013/04/17
Linezolid Zyvoxam oral suspension Antibacterial agent 2010/08/04
Liraglutide Victoza Incretin mimetic agent 2010/05/27
Liraglutide Saxenda Incretin mimetic 2015/05/27
Liraglutide + Insulin Degludec Xultophy Incretin mimetic + insulin 2018/06/06
Lisdexamfetamine Vyvanse CNS stimulant 2010/04/20
Lithium, sustained release Lithmax Antimanic agents
Lorlatinib Lorbrena Tyrosine kinase inhibitor 2019/04/22
Loteprednol etabonate Lotemax Corticosteroid 2009/01
Lumiracoxib Prexige COX-2 inhibitor 2006/11
Lurasidone Latuda Atypical antipsychotic 2012/09/12
Syndicate content